Swiss Pharma becomes first Nigerian company to receive WHO prequalification for Zinc Sulphate and Sulfadoxine-Pyrimethamine tablets, supported by USAID.

USAID and Swiss Pharma (Swipha) have achieved a milestone in West Africa's pharmaceutical industry. Swipha became the first Nigerian company to receive WHO prequalification for two essential medicines, Zinc Sulphate and Sulfadoxine-Pyrimethamine tablets. This achievement, supported by USAID, helps improve access to life-saving medicines in the region, enabling Swipha to supply essential medicines globally and contribute to child health and maternal care.

August 27, 2024
153 Articles